You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Neoadjuvant Chemoimmunotherapy

Showing 1 - 25 of 3,017
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neoadjuvant Chemoimmunotherapy in Resectable Locally Advanced

Completed
  • Oral Cancer
  • PD-1 inhibitor+carboplatin+albumin-bound paclitaxel
  • Guangzhou, Guangdong, China
    Sun Yat-Sen Memorial Hospital
Nov 20, 2023

Glioblastoma Trial in Louisville (Pembrolizumab and Temozolomide)

Recruiting
  • Glioblastoma
  • Pembrolizumab and Temozolomide
  • Louisville, Kentucky
    James Graham Brown Cancer Ctr.
Jan 18, 2023

Neoadjuvant Chemoimmunotherapy in Non-small Cell Lung Cancer

Recruiting
  • Non-small Cell Lung Cancer
  • +2 more
  • CT/PET/WSI-based Deep Learning Signature
  • Zunyi, Guizhou, China
  • +2 more
Jun 27, 2023

Stage I Colon Cancer, Stage II Colon Cancer, Stage III Colon Cancer Trial in Houston (Tecentriq 1200 MG in 20 ML Injection +

Not yet recruiting
  • Stage I Colon Cancer
  • +2 more
  • Tecentriq 1200 MG in 20 ML Injection + Capecitabine 1000 mg/m2 + Oxaliplatin 130 mg/m2
  • +2 more
  • Houston, Texas
    Baylor College of Medicine
May 22, 2023

Esophageal Squamous Cell Carcinoma, Neoadjuvant Chemoimmunotherapy Trial (neoadjuvant anti-PD-1 (Keytruda) plus chemo)

Not yet recruiting
  • Esophageal Squamous Cell Carcinoma
  • Neoadjuvant Chemoimmunotherapy
  • neoadjuvant anti-PD-1 (Keytruda) plus chemotherapy
  • (no location specified)
Feb 14, 2023

Squamous Cell Carcinoma of Head and Neck, Neoadjuvant Therapy, Resection Margin Trial in Wuhan (Reducing Excision Margins)

Active, not recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • +2 more
  • Reducing Excision Margins
  • Wuhan, Hubei, China
    Zhanjie Zhang
Jul 11, 2022

Larynx Cancer, Hypopharyngeal Cancer Trial in Shanghai (procedure, radiation, drug)

Recruiting
  • Larynx Cancer
  • Hypopharyngeal Cancer
  • Surgery
  • +2 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Sep 9, 2023

Esophageal Squamous Cell Carcinoma, Neoadjuvant Chemoimmunotherapy, Adjuvant Therapy Trial in Shanghai (Tislelizumab)

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • +2 more
  • Shanghai, Shanghai, China
    Shanghai chest hospital
Sep 24, 2023

Triple Negative Breast Cancer, Breast Cancer Trial in United States (Carboplatin, Docetaxel, Doxorubicin)

Recruiting
  • Triple Negative Breast Cancer
  • Breast Cancer
  • Fairway, Kansas
  • +5 more
Jan 26, 2023

Oral Squamous Cell Carcinoma, Oropharyngeal Squamous Cell Carcinoma Trial in China (Tislelizumab, Albumin-Bound Paclitaxel,

Recruiting
  • Oral Squamous Cell Carcinoma
  • Oropharyngeal Squamous Cell Carcinoma
  • Beijing, Beijing, China
  • +13 more
Aug 22, 2023

Head and Neck Squamous Cell Carcinoma, Neoadjuvant Treatment Trial in Zhuhai (Tislelizumab, Low-dose radiotherapy)

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Neoadjuvant Treatment
  • Zhuhai, Guangdong, China
    Fifth Affilliated Hospital of Sun Yat-sen University
Apr 22, 2022

Stomach Tumors, Esophagogastric Junction Disorder, Neoadjuvant Therapy Trial in Shanghai (drug, radiation, procedure)

Recruiting
  • Stomach Neoplasms
  • +7 more
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Dec 3, 2021

Cancer of Ovary, Cancer of the Ovary, Tumors, Ovarian Trial in Pittsburgh (Cisplatin + celecoxib + DC vaccine, Cisplatin + CKM +

Suspended
  • Cancer of Ovary
  • +5 more
  • Cisplatin + celecoxib + DC vaccine
  • Cisplatin + CKM + Celecoxib + DC Vaccine
  • Pittsburgh, Pennsylvania
  • +1 more
Dec 15, 2021

Ovarian Tumor Epithelial, Ovarian Cancer, Fallopian Tube Tumors Trial in India (Oregovomab, Paclitaxel, Carboplatin)

Not yet recruiting
  • Ovarian Neoplasm Epithelial
  • +4 more
  • Oregovomab
  • +3 more
  • Visakhapatnam, Andhra Pradesh, India
  • +7 more
Dec 7, 2022

Non Small Cell Lung Cancer Trial in Wuhan (Carrelizumab, Pemetrexed (Nonsquamous NSCLC) or Nab-paclitaxel(Squamous NSCLC),

Recruiting
  • Non Small Cell Lung Cancer
  • Wuhan, China
    Wuhan Union Hospital
Aug 27, 2021

ctDNA Testing Plus AI-based Pathology in Resectable LSCC

Recruiting
  • Lung Squamous Cell Carcinoma
  • WES and ctDNA detection
  • Changsha, Hunan, China
    Department of Thoracic Surgery, Second Xiangya Hospital of Centr
Mar 18, 2023

Locally Advanced, NSCLC Trial in Shanghai (drug, procedure, radiation)

Recruiting
  • Locally Advanced
  • Non-small Cell Lung Cancer
  • Shanghai, China
    Shanghai Pulmonary Hospital
Mar 14, 2023

ctDNA-MRD in Stage IIIB-C NSCLC Patients Treated With Induction

Not yet recruiting
  • Non-small Cell Lung Cancer
  • NGS and ctDNA-MRD detection
  • Changsha, Hunan, China
    Department of Thoracic Surgery, Second Xiangya Hospital of Centr
Apr 18, 2023

Stomach Tumors, Digestive System Tumors, Tumors Trial in Fuzhou (Camrelizumab, SOX, Surgery)

Active, not recruiting
  • Stomach Neoplasms
  • +5 more
  • Fuzhou, Fujian, China
    The Second Affiliated Hospital of Fujian Medical University
Nov 1, 2022

New Prognostic Index for Neoadjuvant Chemotherapy Outcome in

Enrolling by invitation
  • Ovarian Cancer
  • +2 more
  • CRS scoring
  • Routine blood laboratory testing before treatment
  • Guangzhou, Guangdong, China
    The Sun Yat-sen Memorial Hospital of Sun Yat-sen University
Nov 2, 2023

Breast Cancer, Triple Negative Breast Cancer, Dietary Exposure Trial (Control diet (ARM A) or Fasting-Like Approach (FLA, ARM

Not yet recruiting
  • Breast Cancer
  • +3 more
  • Control diet (ARM A) or Fasting-Like Approach (FLA, ARM B)
  • (no location specified)
Feb 28, 2023

Lung Adenocarcinoma Stage III, Lung Adenocarcinoma Stage IV, EGFR Gene Mutation Trial in Shanghai (Furmonertinib, Bevacizumab)

Recruiting
  • Lung Adenocarcinoma Stage III
  • +2 more
  • Shanghai, Shanghai, China
    Shanghai Pulmonary Hospital
Aug 13, 2022

Neoadjuvant Immunotherapy in Advanced NSCLC

Not yet recruiting
  • Lung Cancer, Non-small Cell
  • Immunotherapy
  • San Francisco, California
    Power Life Sciences
Jan 21, 2022

Head and Neck Squamous Cell Carcinoma Trial in Guangzhou (Nab paclitaxel, Carboplatin, adelbelimumab)

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Nab paclitaxel
  • +2 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital
Aug 24, 2023

Adenocarcinoma, Stomach Tumor, Gastroesophageal-junction Cancer Trial in Shanghai (radiation, biological, drug, procedure)

Recruiting
  • Adenocarcinoma
  • +8 more
  • Radiotherapy targeted to the primary lesion
  • +7 more
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Nov 7, 2023